{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:18:06Z","timestamp":1793830686750,"version":"4.6.1"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI23\/00046"],"award-info":[{"award-number":["PI23\/00046"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["RD24\/0007\/0031"],"award-info":[{"award-number":["RD24\/0007\/0031"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Carlos III Health Institute","doi-asserted-by":"publisher","award":["PI24\/00554"],"award-info":[{"award-number":["PI24\/00554"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016145","name":"Ministerio de Sanidad, Consumo y Bienestar Social","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016145","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["PI23\/00046"],"award-info":[{"award-number":["PI23\/00046"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["RD24\/0007\/0031"],"award-info":[{"award-number":["RD24\/0007\/0031"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.semarthrit.2025.152833","type":"journal-article","created":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T20:07:59Z","timestamp":1758571679000},"page":"152833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort"],"prefix":"10.1016","volume":"75","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8569-861X","authenticated-orcid":false,"given":"Javier","family":"Llorca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0197-5267","authenticated-orcid":false,"given":"Iv\u00e1n","family":"Ferraz-Amaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7748-853X","authenticated-orcid":false,"given":"Santos","family":"Casta\u00f1eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-8401-931X","authenticated-orcid":false,"given":"Zulema","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-1189-2380","authenticated-orcid":false,"given":"Fernando","family":"S\u00e1nchez-Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7895-8249","authenticated-orcid":false,"given":"Carmen","family":"Garc\u00eda-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4483-9778","authenticated-orcid":false,"given":"Carlos","family":"Gonz\u00e1lez-Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7924-7406","authenticated-orcid":false,"given":"Miguel \u00c1ngel","family":"Gonz\u00e1lez-Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.semarthrit.2025.152833_bib0001","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.berh.2016.10.006","article-title":"Cardiovascular disease in inflammatory rheumatic diseases","volume":"30","author":"Casta\u00f1eda","year":"2016","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152833_bib0002","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1136\/annrheumdis-2017-211735","article-title":"Impact of risk factors associated with cardiovascular outcomes in patients with rheumatoid arthritis","volume":"77","author":"Crowson","year":"2018","journal-title":"Ann Rheum Dis"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152833_bib0003","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003485","article-title":"Cardiovascular disease risk in patients with inflammatory arthritis nowadays still substantially elevated","volume":"9","author":"Raadsen","year":"2023","journal-title":"RMD Open"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152833_bib0004","first-page":"1013","article-title":"Cardiovascular risk assessment in patients with rheumatoid arthritis: The relevance of clinical, genetic and serological markers","volume":"15","author":"L\u00f3pez-Mej\u00edas","year":"2016","journal-title":"AutoimmunRev"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152833_bib0005","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.semarthrit.2014.12.002","article-title":"Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: Baseline data of the CARMA Project","volume":"44","author":"Casta\u00f1eda","year":"2015","journal-title":"Semin Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152833_bib0006","article-title":"Evaluating the reliability of cardiovascular risk scales in patients with chronic inflammatory rheumatic diseases","volume":"72","author":"Llorca","year":"2025","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2025.152833_bib0007","first-page":"keaf168","article-title":"Performance of four cardiovascular risk scales in chronic inflammatory rheumatic disease patients: 10-year follow-up data","author":"Llorca","year":"2025","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152833_bib0008","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1161\/CIRCULATIONAHA.123.067626","article-title":"Development and Validation of the American Heart Association's PREVENT Equations","volume":"149","author":"Khan","year":"2024","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152833_bib0009","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/art.1780310302","article-title":"The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis","volume":"31","author":"Arnett","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152833_bib0010","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/art.1780380107","article-title":"Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis","volume":"38","author":"Prevoo","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152833_bib0011","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1093\/rheumatology\/ken004","article-title":"Disease Activity Score 28-ESR bears a similar relationship to treatment decisions across different rheumatologists, but misclassification is too frequent to replace physician judgement","volume":"47","author":"Taylor","year":"2008","journal-title":"Rheumatology (Oxford)"},{"issue":"11","key":"10.1016\/j.semarthrit.2025.152833_bib0012","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1136\/ard.2009.122226","article-title":"Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity","volume":"69","author":"Solomon","year":"2010","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"10.1016\/j.semarthrit.2025.152833_bib0013","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1002\/art.39098","article-title":"Disease activity in rheumatoid arthritis and the risk of cardiovascular events","volume":"67","author":"Solomon","year":"2015","journal-title":"Arthritis Rheumatol"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152833_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105401","article-title":"Time-averaged DAS28 and HAQ predict cardiovascular disease in patients with rheumatoid arthritis: Data from KORONA registry","volume":"89","author":"Min","year":"2022","journal-title":"Joint Bone Spine"},{"issue":"25","key":"10.1016\/j.semarthrit.2025.152833_bib0015","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1093\/eurheartj\/ehab309","article-title":"SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe","volume":"42","year":"2021","journal-title":"Eur Heart J"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152833_bib0016","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.recesp.2010.12.011","article-title":"Validez relativa de la estimaci\u00f3n del riesgo cardiovascular a 10 a\u00f1os en una cohorte poblacional del estudio REGICOR [Relative validity of the 10-year cardiovascular risk estimate in a population cohort of the REGICOR study]","volume":"64","author":"Marrugat","year":"2011","journal-title":"Rev Esp Cardiol"},{"issue":"3","key":"10.1016\/j.semarthrit.2025.152833_bib0017","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/s12016-017-8635-2","article-title":"Sex and Cardiovascular Involvement in Inflammatory Joint Diseases","volume":"56","author":"Casta\u00f1eda","year":"2019","journal-title":"Clin Rev Allergy Immunol"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152833_bib0018","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.semarthrit.2008.02.001","article-title":"Endothelial dysfunction, carotid intima-media thickness, and accelerated atherosclerosis in rheumatoid arthritis","volume":"38","author":"Gonzalez-Gay","year":"2008","journal-title":"Semin Arthritis Rheum"},{"issue":"21","key":"10.1016\/j.semarthrit.2025.152833_bib0019","doi-asserted-by":"crossref","first-page":"4975","DOI":"10.3390\/jcm10214975","article-title":"Moderate and High Disease Activity Predicts the Development of Carotid Plaque in Rheumatoid Arthritis Patients without Classic Cardiovascular Risk Factors: Six Years Follow-Up Study","volume":"10","author":"Ferraz-Amaro","year":"2021","journal-title":"J Clin Med"},{"issue":"1","key":"10.1016\/j.semarthrit.2025.152833_bib0020","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s13075-021-02542-7","article-title":"Disease activity influences the reclassification of rheumatoid arthritis into very high cardiovascular risk","volume":"23","author":"Ferraz-Amaro","year":"2021","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"10.1016\/j.semarthrit.2025.152833_bib0021","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1002\/acr.23926","article-title":"Coexistent Hyperuricemia and Gout in Rheumatoid Arthritis: Associations With Comorbidities, Disease Activity, and Mortality","volume":"72","author":"Chiou","year":"2020","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"10.1016\/j.semarthrit.2025.152833_bib0022","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2025-005464","article-title":"Influence of body mass index on cardiovascular risk in rheumatoid arthritis varies across anti-citrullinated protein antibody status and biologic use","volume":"11","author":"Karpouzas","year":"2025","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.semarthrit.2025.152833_bib0023","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1007\/s00296-025-05838-y","article-title":"Methotrexate associates with ischemic cardiovascular risk reduction in males but not females: a transatlantic cardiovascular consortium for people with rheumatoid arthritis observational study","volume":"45","author":"Karpouzas","year":"2025","journal-title":"Rheumatol Int"},{"issue":"4","key":"10.1016\/j.semarthrit.2025.152833_bib0024","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1136\/ard.2010.129916","article-title":"Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis","volume":"70","author":"Greenberg","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002045?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017225002045?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T13:54:14Z","timestamp":1765979654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017225002045"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":24,"alternative-id":["S0049017225002045"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152833","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease activity predicts the development of cardiovascular events in patients with rheumatoid arthritis from the CARMA cohort","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2025.152833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152833"}}